Photo of Michael Dennis (Mick) Murray
Michael Dennis (Mick) Murray
Distinguished Professor Emeritus of Pharmacy Practice
E-mail: murraymd@purdue.edu
Education
1992 M.P.H., Indiana University
1988 Pharmacoepidemiology Fellowship, Regenstrief Institute
1977 Hospital Pharmacy Residency, Thomas Jefferson University Hospital
1977 Pharm.D., Duquesne University
1975 B.Sc., Pharmacy, Duquesne University
Research

Improving medication use and safety in people with chronic diseases

Factors affecting patient adherence to their chronic medications

Pharmacoepidemiology of chronically administered medications

Pharmacy services research in ambulatory settings

Health care utilization of low-income minority people with chronic diseases

Teaching

PHRM 849, Population Health Management

PHPR 664, Graduate Student Research

Honors and Credentials

Fellow of the International Society for Pharmacoepidemiology

Fellow of the College of the American College of Clinical Pharmacy

Distinguished Professor of Pharmacy

Endowed Chair of Medication Safety

Bucke Professor of Pharmacy

Purdue University Faculty Scholar Award

Award for Excellence in Health Science Research, Indiana’s Premier Award in Health Services Research

Representative Publications

1.  Marcum Z, Hanlon J, Murray MD, Improving Medication Adherence and Health Outcomes in Older Adults:  A Review of Evidence from Randomized Controlled Trials, Drugs and Aging 2017;34(3):191-201. doi: 10.1007/s40266-016-0433-7.

2.  Chin J, Madison A, Gao X, Graumlich JF, Conner-Garcia T, Murray MD, Morrow DG. Cognition and Health Literacy in Older Adults' Recall of Self-Care Information. Gerontologist, 2017; 57(2): 261-8.

3.  Murray MD. Use of Data from Electronic Health Records for Pharmacoepidemiology. Current Epidemiology Reports 2014 Dec;11(4):1:186–193.

4.  Aljadhey H, Mahmoud MA, Ahmed Y, Khan R, Zouein S, Alshanawani S, Mayet A, Alshaikh M, Kalagie N, Al Tawil E, El Kinge ARA, Arwadi A, Alyahya M, Murray MD, Bates D. Incidence of Adverse Drug Events in Public and Private Hospitals in Riyadh, Saudi Arabia: The (ADESA) Prospective Cohort Study. BMJ Open. 2016; Jul 12;6(7):e010831. doi:10.1136/bmjopen-2015-010831.

5.  Murray MD, Ritchey ME, Wu J, Tu W. Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients with Cardiovascular Disease. Arch Intern Med 2009; 169(8):757-63.

6.  Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther 2009; 85(6):651-58.

7.  Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007; 146(10):714-725.

8.  Weinberger M,  Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Seshadri R, Caffrey H, Roesner JF, Smith FA,  Newell J, Collins JC, McDonald CJ, Tierney W. The Effectiveness of Pharmacist Care for Patients with Reactive Airways Disease: A Randomized, Controlled Trial. JAMA 2002; 288:1594-1602. 

9.  Murray MD, Lane KA, Gao S, Evans RM, Unverzagt FW, Hall KS, Hendrie HC. Preservation of cognitive function with antihypertensive medications: A longitudinal analysis of a community-based sample of African-Americans. Archives of Internal Medicine 2002; 162:2090-2096.

10. Murray MD, Brater DC. Renal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs. Ann Rev Pharmacol Toxicol 1993; 32:435-65.